0000000000075155

AUTHOR

Kilian M. Gust

showing 6 related works from this author

Trend analysis and regional tumor incidence in Germany for testicular cancer between 2003 and 2014

2019

BACKGROUND Testicular germ cell tumor (TGCT) is one the most common solid tumors in men between the age of 15 and 35 with an overall incidence rate of 1-1.5 %. Epidemiologic studies have demonstrated different incidence patterns in western civilized countries with overall rising incidence trends. OBJECTIVE To analyze differences in regional tumor incidence rates for TGCT and perform a trend analysis for TGCT between 2003 and 2014 in Germany. MATERIAL AND METHODS TGCT cases in Germany which were diagnosed between 2003 and 2014 were provided by the Robert-Koch-Institute, Berlin. For statistical analysis, cluster and spatial scan tests according to Kulldorff were used for cases with seminoma a…

AdultMaleOncologymedicine.medical_specialtyTumor incidenceAdolescentendocrine system diseasesUrologyEndocrinology Diabetes and MetabolismTesticular Germ Cell Tumorurologic and male genital diseasesYoung Adult03 medical and health sciences0302 clinical medicineEndocrinologyTesticular NeoplasmsGermanyStatistical significanceInternal medicineEpidemiologymedicineHumansChildTesticular cancerAgedAged 80 and over030219 obstetrics & reproductive medicinebusiness.industryIncidenceIncidence (epidemiology)SeminomaMiddle AgedNeoplasms Germ Cell and Embryonalmedicine.diseaseSeminomaTrend analysisReproductive MedicinebusinessAndrology
researchProduct

Nationwide analysis on the impact of socioeconomic land use factors and incidence of urothelial carcinoma

2017

Incidence rates for urothelial carcinoma (UC) have been reported to differ between countries within the European Union (EU). Besides occupational exposure to chemicals, other substances such as tobacco and nitrite in groundwater have been identified as risk factors for UC. We investigated if regional differences in UC incidence rates are associated with agricultural, industrial and residential land use.Newly diagnosed cases of UC between 2003 and 2010 were included. Information within 364 administrative districts of Germany from 2004 for land use factors were obtained and calculated as a proportion of the total area of the respective administrative district and as a smoothed proportion. Fur…

AdultMale0301 basic medicineUrologic NeoplasmsCancer ResearchMultivariate analysisAdolescentEpidemiologyYoung Adult03 medical and health sciences0302 clinical medicineRisk FactorsGermanyHumansIndustryMedicinemedia_common.cataloged_instanceYoung adultEuropean unionChildSocioeconomic statusAgedmedia_commonAged 80 and overLand usebusiness.industryIncidenceIncidence (epidemiology)SmokingAgricultureEnvironmental ExposureEnvironmental exposureMiddle Aged030104 developmental biologySocioeconomic FactorsOncologyAdministrative District030220 oncology & carcinogenesisFemalebusinessDemographyCancer Epidemiology
researchProduct

DHH is an independent prognosticator of oncologic outcome of clear cell renal cell carcinoma.

2014

Aberrant HH signaling has proved important in the pathogenesis of several solid cancers. Limited in vitro analyses suggested an oncogenic role for HH in renal cell carcinoma. In this explorative study we sought to validate aberrant HH expression in patients with renal cell carcinoma.A tissue microarray was constructed from 140 radical nephrectomy specimens of patients with clear cell renal cell carcinoma. We performed immunohistochemistry for Ki67 and HH pathway biomarkers, including PTCH1, Smo, SHH, IHH, DHH, Gli1, Gli2 and Gli3. Staining intensity was measured by automated image processing and related to tumor stage and grade. The impact of biomarker expression on cancer specific survival…

MalePathologymedicine.medical_specialtyUrologymedicine.medical_treatmentRenal cell carcinomamedicineCarcinomaHumansHedgehog ProteinsCarcinoma Renal CellDesert hedgehogAgedRetrospective StudiesKidneyTissue microarraybusiness.industryMiddle Agedmedicine.diseasePrognosisNephrectomyKidney NeoplasmsClear cell renal cell carcinomamedicine.anatomical_structurePTCH1Cancer researchFemalebusinessThe Journal of urology
researchProduct

What should be the patient's preference regarding the choice of hospital in the case of radical cystectomy? Evaluation of early complications…

2016

Jens Mani,1 Stefan Vallo,1 Maximilian P Brandt,1 Kilian M Gust,1 Claudia Bartsch,1 Johannes Daechert,1 Igor Tsaur,1 Georg Bartsch,2,* Axel Haferkamp1,* 1Department of Urology, Goethe University Hospital, Frankfurt am Main, 2Department of Urology, Johannes Gutenberg University Hospital Mainz, Mainz, Germany *These authors contributed equally to this work Purpose: This study compares early complications after cystectomy and urinary diversion (UD) stratified by the surgical focus and case load of two different department chairpersons in a single institution in two time periods. Creating clear data about complications that can affect the quality of life is an important tool for patient…

medicine.medical_specialtyClavien-Dindo Classificationbusiness.industryHealth Policymedicine.medical_treatmentSignificant differenceUrinary diversion030232 urology & nephrologyMedicine (miscellaneous)University hospitalSurgeryCystectomy03 medical and health sciences0302 clinical medicineVolume settingQuality of lifePatient Preference and Adherence030220 oncology & carcinogenesisMedicinebusinessComplicationPharmacology Toxicology and Pharmaceutics (miscellaneous)Social Sciences (miscellaneous)Patient Preference and Adherence
researchProduct

Increased tumor vascularization is associated with the amount of immune competent PD‑1 positive cells in testicular germ cell tumors

2018

Testicular germ cell cancer in a metastatic state is curable with a cisplatin‑based first line chemotherapy. However, 10‑15% of these patients are resistant to first line chemotherapy and are thus left with only palliative options. Immunotherapies and inhibition of angiogenesis used in multiple types of cancer; however, the molecular context of angiogenesis and immune checkpoints in the development and progression of testicular cancers is still unknown. Therefore, the present study performed tissue micro array based analysis of 84 patients with immunohistochemistry of programmed cell death protein 1 (PD‑1), programmed cell death ligand 1 (PD‑L1) and vascular endothelial growth factor recept…

0301 basic medicineendocrine systemCancer ResearchOncogeneAngiogenesisbusiness.industrymedicine.medical_treatmentCancerImmunotherapyCell cyclemedicine.disease03 medical and health sciences030104 developmental biology0302 clinical medicineImmune systemOncology030220 oncology & carcinogenesismedicineCancer researchCytotoxic T cellddc:610businessTesticular cancerOncology Letters
researchProduct

Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach

2013

Orthotopic bladder cancer xenografts are essential for testing novel therapies and molecular manipulations of cell lines in vivo. Current xenografts rely on tumor cell inoculation by intravesical instillation or direct injection into the bladder wall. Instillation is limited by the lack of cell lines that are tumorigenic when delivered in this manner. The invasive model inflicts morbidity on the mice by the need for laparotomy and mobilization of the bladder. Furthermore this procedure is complex and time-consuming. Three bladder cancer cell lines (UM-UC1, UM-UC3, UM-UC13) were inoculated into 50 athymic nude mice by percutaneous injection under ultrasound guidance. PBS was first injected b…

PathologyMouseTumor PhysiologyCancer Treatmentlcsh:MedicineMiceBasic Cancer ResearchMedicineUltrasonicslcsh:ScienceBladder Cancer and Urothelial Neoplasias of the Urinary TractMultidisciplinaryUltrasoundAnimal ModelsBladder CancerOncolytic VirusesOncologySurgery Computer-AssistedMedicineOncology AgentsFemaleImmunotherapyResearch Articlemedicine.drugmedicine.medical_specialtyClinical Research DesignUrologyTransplantation HeterologousModel OrganismsIn vivoCell Line TumorAnimalsHumansBioluminescence imagingddc:610Animal Models of DiseaseBiologyCell ProliferationCisplatinBladder cancerbusiness.industrylcsh:RCancers and NeoplasmsChemotherapy and Drug Treatmentmedicine.diseaseGemcitabineOncolytic virusTransplantationGenitourinary Tract TumorsUrinary Bladder NeoplasmsFeasibility Studieslcsh:QbusinessPLoS ONE
researchProduct